Healthcare | April 06, 2026
AstraZeneca, Roche-backed study supports risk-based HF screening in diabetes
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
Move aligns global biologics identity under the Biocon Biologics brand
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance
The acquisition brings two commercialized, differentiated medicines—EMPAVELI and SYFOVRE —to Biogen’s growth portfolio
Subscribe To Our Newsletter & Stay Updated
